Appetite loss during chemotherapy is associated with reduced dietary intake and quality of life in patients with gynecologic cancer: a prospective observational study
Appetitverlust während der Chemotherapie ist mit verringerter Nahrungsaufnahme und Lebensqualität bei Patient:innen mit gynäkologischer Krebserkrankung assoziiert: prospektive Beobachtungsstudie
Supportive Care in Cancer · 2026-10 · 34 (10)
DOI: 10.1007/s00520-026-11276-8 ↗Auf einen Blick
Bei Patient:innen mit gynäkologischer Krebserkrankung war Appetitverlust während der Chemotherapie mit geringerer Nahrungsaufnahme und niedrigerer Lebensqualität assoziiert. Geschmackveränderungen waren am engsten damit verbunden.
Fragestellung
Welche diätetischen Veränderungen sind mit Appetitverlust während der Chemotherapie verbunden, und wie hängen sie mit Lebensqualität und unerwünschten Ereignissen zusammen?
Methode
Prospektive einarmige Beobachtungsstudie an einem Zentrum; Ernährung zu Beginn und vor dem zweiten Zyklus mit Ernährungsfragebogen erfasst; Appetitverlust, QOL und unerwünschte Ereignisse mit EORTC QLQ-C30 und PRO-CTCAE.
Ergebnisse
Von 105 Patient:innen berichteten 41 (39,0 %) vor dem dritten Chemotherapiezyklus Appetitverlust. Dann nahmen Energie- und Makronährstoffzufuhr stärker ab; Appetitverlust war außerdem mit QOL-Abfall assoziiert.
Schlussfolgerung der Autor:innen
Appetitverlust während der Chemotherapie war mit reduzierter Nahrungsaufnahme und niedrigerer QOL assoziiert. Geschmackveränderungen waren eng mit Appetitverlust verbunden; dies spricht für klinische Relevanz in der Supportivversorgung.
Kernaussagen
- 41 von 105 Patient:innen berichteten Appetitverlust
- Geringere Energie- und Makronährstoffzufuhr bei Appetitverlust
- Appetitverlust und QOL-Abfall sowie Geschmackveränderungen waren assoziiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Beobachtungsstudie in der Zeitschrift Supportive Care in Cancer, online erschienen am 02.10.2026. Verfasst von Ayami Koike und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Graduate School of Medicine and Faculty of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, K…. Hauptthemen laut MEDLINE: Genital Neoplasms, Female, Quality of Life, Antineoplastic Agents, Anorexia. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
Appetite loss is common during chemotherapy. However, its association with dietary intake and quality of life (QOL) in patients with gynecologic cancer remains unclear. This study aimed to clarify the dietary changes associated with appetite loss and investigate their association with QOL and adverse events.
Methods
Patients with gynecologic cancer receiving chemotherapy were enrolled in this single-center longitudinal observational study. Dietary intake was assessed at baseline and before the third chemotherapy cycle using a diet history questionnaire. Appetite loss, QOL, and adverse events were evaluated using the EORTC QLQ-C30 and PRO-CTCAE. Sensitivity analyses addressed pre-existing appetite loss and postoperative effects. A complementary analysis of a separate cohort examined the association between appetite loss and longitudinal QOL changes.
Results
Among 105 patients, 41 (39.0%) reported appetite loss before the third chemotherapy cycle. The appetite loss group showed greater reductions in energy and macronutrient intake, whereas macronutrient composition did not differ between the groups. Absolute micronutrient intake broadly decreased, but no difference remained significant after energy adjustment. Among adverse events, taste changes were most closely associated with appetite loss. Appetite loss was also associated with QOL decline, and dietary findings were directionally consistent in sensitivity analyses. The complementary analysis showed appetite loss was consistently associated with QOL fluctuations.
Conclusion
Appetite loss during chemotherapy was associated with reduced dietary intake and lower QOL. Taste alterations were closely associated with appetite loss. These findings support appetite loss as a clinically relevant target for the supportive care of patients with gynecologic cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Graduate School of Medicine and Faculty of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.
- Department of Gynecology and Obstetrics, Graduate School of Medicine and Faculty of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. rin0617@kuhp.kyoto-u.ac.jp.
- Department of Obstetrics and Gynecology, Shizuoka General Hospital, Shizuoka, Japan.
- Department of Diabetes, Endocrinology and Nutrition, Kyoto University Graduate School of Medicine, Kyoto, Japan.
- Department of Obstetrics and Gynecology, Kitano Hospital, Osaka, Japan.
- Department of Obstetrics and Gynecology, Osaka Red Cross Hospital, Osaka, Japan.
Förderung
- JSPS KAKENHI
Zitieren
APA
Koike, A., Mizuno, R., Higashiyama, N., Inayama, Y., Umemiya, M., Ikeda, K., Kubo, N., Tokushige, Y., Nagasawa, T., Matsumura, N., Miyamoto, T., Taki, M., Yamanoi, K., Murakami, R., Yamaguchi, K., & Mandai, M. (2026). Appetite loss during chemotherapy is associated with reduced dietary intake and quality of life in patients with gynecologic cancer: a prospective observational study. Supportive Care in Cancer, 34(10). https://doi.org/10.1007/s00520-026-11276-8
Vancouver
Koike A, Mizuno R, Higashiyama N, Inayama Y, Umemiya M, Ikeda K, et al. Appetite loss during chemotherapy is associated with reduced dietary intake and quality of life in patients with gynecologic cancer: a prospective observational study. Supportive Care in Cancer. 2026;34(10). doi:10.1007/s00520-026-11276-8
BibTeX
@article{Koike2026,
author = {Koike, Ayami and Mizuno, Rin and Higashiyama, Nozomi and Inayama, Yoshihide and Umemiya, Maki and Ikeda, Kaori and Kubo, Nozomi and Tokushige, Yu and Nagasawa, Takayuki and Matsumura, Noriomi and Miyamoto, Taito and Taki, Mana and Yamanoi, Koji and Murakami, Ryusuke and Yamaguchi, Ken and Mandai, Masaki},
title = {Appetite loss during chemotherapy is associated with reduced dietary intake and quality of life in patients with gynecologic cancer: a prospective observational study},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {10},
doi = {10.1007/s00520-026-11276-8}
}
EUVIMED